MEI Total Assets from 2010 to 2025
| MEIP Stock | USD 2.43 0.03 1.22% |
Total Assets | First Reported 2002-06-30 | Previous Quarter 27.8 M | Current Value 24.4 M | Quarterly Volatility 57.8 M |
Check MEI Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MEI Pharma's main balance sheet or income statement drivers, such as Interest Expense of 310.3 K, Selling General Administrative of 28.1 M or Total Revenue of 78.8 M, as well as many indicators such as Price To Sales Ratio of 0.32, Dividend Yield of 0.49 or PTB Ratio of 0.63. MEI financial statements analysis is a perfect complement when working with MEI Pharma Valuation or Volatility modules.
MEI | Total Assets |
Latest MEI Pharma's Total Assets Growth Pattern
Below is the plot of the Total Assets of MEI Pharma over the last few years. Total assets refers to the total amount of MEI Pharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in MEI Pharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. MEI Pharma's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MEI Pharma's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 41.38 M | 10 Years Trend |
|
Total Assets |
| Timeline |
MEI Total Assets Regression Statistics
| Arithmetic Mean | 80,687,954 | |
| Geometric Mean | 57,723,012 | |
| Coefficient Of Variation | 75.39 | |
| Mean Deviation | 48,208,410 | |
| Median | 62,725,013 | |
| Standard Deviation | 60,831,508 | |
| Sample Variance | 3700.5T | |
| Range | 203.4M | |
| R-Value | 0.45 | |
| Mean Square Error | 3167.1T | |
| R-Squared | 0.20 | |
| Significance | 0.08 | |
| Slope | 5,731,327 | |
| Total Sum of Squares | 55507.1T |
MEI Total Assets History
Other Fundumenentals of MEI Pharma
MEI Pharma Total Assets component correlations
Click cells to compare fundamentals
About MEI Pharma Financial Statements
MEI Pharma shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although MEI Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in MEI Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on MEI Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Assets | 47.6 M | 62.7 M |
Additional Tools for MEI Stock Analysis
When running MEI Pharma's price analysis, check to measure MEI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma is operating at the current time. Most of MEI Pharma's value examination focuses on studying past and present price action to predict the probability of MEI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma's price. Additionally, you may evaluate how the addition of MEI Pharma to your portfolios can decrease your overall portfolio volatility.